The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Mechanisms of Nanoparticle Internalization and Transport Across an Intestinal Epithelial Cell Model: Effect of Size and Surface Charge
Open accessAbstract
This study investigated the effect of nanoparticle size (50 and 100 nm) and surface charge on their interaction with Caco-2 monolayers as a model of the intestinal epithelium, including cell internalization pathways and the level of transepithelial transport. Initially, toxicity assays showed that cell viability and cell membrane integrity were dependent on the surface charge and applied mass, number, and total surface area of nanoparticles, as tested in two epithelial cell lines, colon carcinoma Caco-2 and airway Calu-3. This also identified suitable nanoparticle concentrations for subsequent cell uptake experiments. Nanoparticle application at doses below half maximal effective concentration (EC₅₀) revealed that the transport efficiency (ratio of transport to cell uptake) across Caco-2 cell monolayers is significantly higher for negatively charged nanoparticles compared to their positively charged counterparts (of similar size), despite the higher level of internalization of positively charged systems. Cell internalization pathways were hence probed using a panel of pharmacological inhibitors aiming to establish whether the discrepancy in transport efficiency is due to different uptake and transport pathways. Vesicular trans-monolayer transport for both positively and negatively charged nanoparticles was confirmed via inhibition of dynamin (by dynasore) and microtubule network (via nocodazole), which significantly reduced the transport of both nanoparticle systems. For positively charged nanoparticles a significant decrease in internalization and transport (46% and 37%, respectively) occurred in the presence of a clathrin pathway inhibitor (chlorpromazine), macropinocytosis inhibition (42%; achieved by 5-(N-ethyl-N-isopropyi)-amiloride), and under cholesterol depletion (38%; via methyl-β-cyclodextrin), but remained unaffected by the inhibition of lipid raft associated uptake (caveolae) by genistein. On the contrary, the most prominent reduction in internalization and transport of negatively charged nanoparticles (51% and 48%, respectively) followed the inhibition of lipid raft-associated pathway (caveolae inhibition by genistein) but was not significantly affected by the inhibition of clathrin pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Nanomaterials and nanoparticles: Sources and toxicity
Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789
Designing materials for biology and medicine
Langer, R., & Tirrell, D. A. (2004) · Nature · doi:10.1038/nature02388 · Cited by 3,198
Dynasore, a Cell-Permeable Inhibitor of Dynamin
Macia, E., Ehrlich, M., Massol, R., Boucrot, E., Brunner, C., & Kirchhausen, T. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.04.002 · Cited by 1,958
Xia, T., Kovochich, M., Brant, J., Hotze, M., Sempf, J., Oberley, T., Sioutas, C., Yeh, J. I., Wiesner, M. R., & Nel, A. E. (2006) · Nano Letters · doi:10.1021/nl061025k · Cited by 1,918
Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains
Goodman, C. M., McCusker, C. D., Yilmaz, T., & Rotello, V. M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049951i · Cited by 1,601
Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452
New Challenges in Biomaterials
Peppas, N. A., & Langer, R. (1994) · Science · doi:10.1126/science.8134835 · Cited by 1,142
Rejman, J., Bragonzi, A., & Conese, M. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.038 · Cited by 851
Use of cyclodextrins for manipulating cellular cholesterol content
Christian, A. E., Haynes, M. P., Phillips, M. C., & Rothblat, G. H. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34940-3 · Cited by 754
The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and Pitfalls
Vercauteren, D., Vandenbroucke, R. E., Jones, A. T., Rejman, J., Demeester, J., De Smedt, S. C., Sanders, N. N., & Braeckmans, K. (2010) · Molecular Therapy · doi:10.1038/mt.2009.281 · Cited by 689
Nanomaterial cytotoxicity is composition, size, and cell type dependent
Sohaebuddin, S. K., Thevenot, P. T., Baker, D., Eaton, J. W., & Tang, L. (2010) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-7-22 · Cited by 672
Annual Review of Biomedical Engineering
(2017) · Annual Review of Biomedical Engineering · doi:10.1146/bioeng.685 · Cited by 553
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
dos Santos, T., Varela, J., Lynch, I., Salvati, A., & Dawson, K. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024438 · Cited by 445
Harush-Frenkel, O., Rozentur, E., Benita, S., & Altschuler, Y. (2008) · Biomacromolecules · doi:10.1021/bm700535p · Cited by 405
Wong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101154 · Cited by 344
Wang, Z., Li, N., Zhao, J., White, J. C., Qu, P., & Xing, B. (2012) · Chemical Research in Toxicology · doi:10.1021/tx3002093 · Cited by 340
Rieux, A. D., Ragnarsson, E. G. E., Gullberg, E., Préat, V., Schneider, Y.-J., & Artursson, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.015 · Cited by 298
Uptake Mechanism of Oppositely Charged Fluorescent Nanoparticles in HeLa Cells
Dausend, J., Musyanovych, A., Dass, M., Walther, P., Schrezenmeier, H., Landfester, K., & Mailänder, V. (2008) · Macromolecular Bioscience · doi:10.1002/mabi.200800123 · Cited by 297
Delivery into cells: lessons learned from plant and bacterial toxins
Sandvig, K., & van Deurs, B. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302525 · Cited by 273
Effects of Nanoparticle Charge and Shape Anisotropy on Translocation through Cell Membranes
Nangia, S., & Sureshkumar, R. (2012) · Langmuir · doi:10.1021/la303449d · Cited by 225
Rojanasakul, Y., Wang, L.-Y., Bhat, M., Glover, D. D., Malanga, C. J., & Ma, J. K. H. (1992) · Pharmaceutical Research · doi:10.1023/a:1015802427428 · Cited by 213
Kirkham, M., & Parton, R. G. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.11.005 · Cited by 197
Sahlin, S., Hed, J., & Runfquist, I. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90340-x · Cited by 192
In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors
Jain, A., & Jain, S. K. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.08.008 · Cited by 169
Polystyrene nanoparticle trafficking across alveolar epithelium
Yacobi, N. R., DeMaio, L., Xie, J., Hamm-Alvarez, S. F., Borok, Z., Kim, K.-J., & Crandall, E. D. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.02.002 · Cited by 165
Mechanisms of Alveolar Epithelial Translocation of a Defined Population of Nanoparticles
Yacobi, N. R., Malmstadt, N., Fazlollahi, F., DeMaio, L., Marchelletta, R. R., Hamm‐Alvarez, S. F., Borok, Z., Kim, K., & Crandall, E. D. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0138oc · Cited by 153
Transforming Growth Factor-β Receptors Interact with AP2 by Direct Binding to β2 Subunit
Yao, D., Ehrlich, M., Henis, Y. I., & Leof, E. B. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-07-0104 · Cited by 129
The transport pathways of polymer nanoparticles in MDCK epithelial cells
He, B., Jia, Z., Du, W., Yu, C., Fan, Y., Dai, W., Yuan, L., Zhang, H., Wang, X., Wang, J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.100 · Cited by 118
Rappoport, J. Z., Smith, Giroud, Wiggins, Mazzolin, & Dyson (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29334 · Cited by 115
Gekle, M., Drumm, K., Mildenberger, S., Freudinger, R., Gaßner, B., & Silbernagl, S. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.00709.x · Cited by 113
Stuart, A. D., & Brown, T. D. K. (2006) · Journal of Virology · doi:10.1128/jvi.02452-05 · Cited by 110
Cytotoxicity and genotoxicity of nano-silver in mammalian cell lines
Kim, Y., Yang, S. I., & Ryu, J. (2010) · Molecular & Cellular Toxicology · doi:10.1007/s13273-010-0018-1 · Cited by 84
Gekle, M., Freudinger, R., & Mildenberger, S. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0619h.x · Cited by 83
Mineo, C., & Anderson, R. G. W. (2001) · Histochemistry and Cell Biology · doi:10.1007/s004180100289 · Cited by 82
Hasegawa, S., Hirashima, N., & Nakanishi, M. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301573 · Cited by 78
Polystyrene nanoparticle trafficking across MDCK-II
Fazlollahi, F., Angelow, S., Yacobi, N. R., Marchelletta, R. R., Yu, A. S. L., Hamm‐Alvarez, S. F., Borok, Z., Kim, K., & Crandall, E. D. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.01.008 · Cited by 71
Nanoparticle Transport in Epithelial Cells: Pathway Switching Through Bioconjugation
Fowler, R., Vllasaliu, D., Fernández‐Trillo, F., Garnett, M. C., Alexander, C., Horsley, H. T., Smith, B., Whitcombe, I. W. A., Eaton, M., & Stolnik, S. (2013) · Small · doi:10.1002/smll.201202623 · Cited by 64
Self-citationLai, Y., Chiang, P., Blom, J. D., Li, N., Shevlin, K. M., Brayman, T. G., Hu, Y., Selbo, J. G., & Hu, L. (2008) · Nanoscale Research Letters · doi:10.1007/s11671-008-9160-2 · Cited by 46
Vllasaliu, D., Fowler, R., Garnett, M. C., Eaton, M., & Stolnik, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.108 · Cited by 44
Self-citationSurface‐functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium
Sundaram, S., Roy, S. K., Ambati, B. K., & Kompella, U. B. (2009) · The FASEB Journal · doi:10.1096/fj.09-129825 · Cited by 43
Cited by
Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties
Sukhanova, A., Bozrova, S., Sokolov, P., Berestovoy, M., Karaulov, A., & Nabiev, I. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2457-x · Cited by 1,107
Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization
Sanità, G., Carrese, B., & Lamberti, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587012 · Cited by 765
Microplastics: A Real Global Threat for Environment and Food Safety: A State of the Art Review
Ziani, K., Ioniță-Mîndrican, C.-B., Mititelu, M., Neacșu, S. M., Negrei, C., Moroșan, E., Drăgănescu, D., & Preda, O.-T. (2023) · Nutrients · doi:10.3390/nu15030617 · Cited by 716
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
Hua, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00524 · Cited by 527
Metadata
- Authors
- Bannunah, A. M., Vllasaliu, D., Lord, J., & Stolnik, S.
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-10-30
- Volume
- 11
- Issue
- 12
- Pages
- 4363-4373
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W2055570674
- Cited by
- 421
- References
- 44
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.